KPRX logo

Kiora Pharmaceuticals (KPRX)

Profile

Full Name

Kiora Pharmaceuticals, Inc.

Ticker Symbol

KPRX

Exchange

NASDAQ

Country

United States

IPO

February 13, 2015

Indexes

Not included

Employees

12

Key Details

Price

$2.88(+4.36%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$16.00M

Annual EPS

$0.87(+103.59% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 28, 25 HC Wainwright & Co.
Buy
Nov 12, 24 HC Wainwright & Co.
Buy
Aug 22, 24 HC Wainwright & Co.
Buy
Jul 23, 24 HC Wainwright & Co.
Buy
May 20, 24 HC Wainwright & Co.
Buy
Mar 27, 24 HC Wainwright & Co.
Buy
Feb 9, 24 HC Wainwright & Co.
Buy
Nov 13, 23 HC Wainwright & Co.
Buy
Nov 6, 23 HC Wainwright & Co.
Buy
Aug 24, 23 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Kiora Pharmaceuticals?
  • Does Kiora Pharmaceuticals pay dividends?
  • What sector is Kiora Pharmaceuticals in?
  • What industry is Kiora Pharmaceuticals in?
  • What country is Kiora Pharmaceuticals based in?
  • When did Kiora Pharmaceuticals go public?
  • Is Kiora Pharmaceuticals in the S&P 500?
  • Is Kiora Pharmaceuticals in the NASDAQ 100?
  • Is Kiora Pharmaceuticals in the Dow Jones?
  • When was Kiora Pharmaceuticals's last earnings report?
  • When does Kiora Pharmaceuticals report earnings?
  • Should I buy Kiora Pharmaceuticals stock now?

What is the ticker symbol for Kiora Pharmaceuticals?

The ticker symbol for Kiora Pharmaceuticals is NASDAQ:KPRX

Does Kiora Pharmaceuticals pay dividends?

No, Kiora Pharmaceuticals does not pay dividends

What sector is Kiora Pharmaceuticals in?

Kiora Pharmaceuticals is in the Healthcare sector

What industry is Kiora Pharmaceuticals in?

Kiora Pharmaceuticals is in the Biotechnology industry

What country is Kiora Pharmaceuticals based in?

Kiora Pharmaceuticals is headquartered in United States

When did Kiora Pharmaceuticals go public?

Kiora Pharmaceuticals's initial public offering (IPO) was on February 13, 2015

Is Kiora Pharmaceuticals in the S&P 500?

No, Kiora Pharmaceuticals is not included in the S&P 500 index

Is Kiora Pharmaceuticals in the NASDAQ 100?

No, Kiora Pharmaceuticals is not included in the NASDAQ 100 index

Is Kiora Pharmaceuticals in the Dow Jones?

No, Kiora Pharmaceuticals is not included in the Dow Jones index

When was Kiora Pharmaceuticals's last earnings report?

Kiora Pharmaceuticals's most recent earnings report was on May 12, 2021

When does Kiora Pharmaceuticals report earnings?

The date for Kiora Pharmaceuticals's next earnings report has not been announced yet

Should I buy Kiora Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page